CareFusion, which is now a part of Becton, Dickinson and Company (BDX -Analyst Report), and WellSpan Health jointly announced that the former’s Alaris System has been successfully deployed across all four WellSpan hospitals.
Infusion device interoperability helps connect Alaris System smart infusion pumps with a hospital’s electronic health record (EHR) system. Infusion device management software like the Alaris System is designed to help deliver better healthcare to patients. The Alaris System can be wirelessly preset with infusion order parameters directly from the hospital’s EHR.
It is aimed at reducing the possibility of harmful and costly intravenous (IV) medication programming errors at a patient’s bedside. The infusion pump is pre-populated with patient’s medication structure, which eliminates the need of manually programming the pump using a keypad. Automatic programming helps to obliterate probabilities of human error and thus ensures accurate IV medication administration and documentation.
The collaboration comes close on the heels of the KLAS recognition for Alaris System. The Alaris System intelligent infusion platform was recently rated as the smart pump industry leader for interoperability with electronic medical records (EMRs) in the Smart Pump/EMR Integration report.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The report from KLAS, an organization that independently monitors health care information technology performance, highlighted that the Alaris System has the most number of healthcare organizations live with EMR interoperability solutions.
We feel that the coveted recognition, followed by the WellSpan collaboration, will help further enhance visibility of the Alaris System. It will, in turn, generate more sales and improve top-line growth at the company.
Meanwhile, while Becton, Dickinson is building focus on CareFusion’s core product lines, it is reportedly contemplating the sale of the V. Mueller surgical instruments business. According to a report by Reuters, the company has hired investment bank JPMorgan Chase & Co. to aid the potential sale of the surgical instruments business, which is expected to yield around $500 million.
The CareFusion merger has opened up significant opportunities for Becton, Dickinson. The combined manufacturing footprint and operations and lower overhead expenses should result in significant cost savings, going forward.
Zacks Rank
Becton, Dickinson currently has a Zacks Rank #3 (Hold). Better-ranked medical stocks at the current moment include AMN Healthcare Services (AHS – Snapshot Report), Cancer Genetics (CGIX – Snapshot Report) and INC Research Holdings (INCR– Snapshot Report). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Date: June 12, 2015